In a mouse model of colitis-associated CRC, the levels of CXCR2 ligands were significantly elevated in inflamed colonic mucosa and tumors compared with in adjacent normal mucosa, and CXCR2+ MDSC accelerated tumor growth by inhibiting CD8+ T cell cytotoxicity activity [21]. This evidence concerns the gene CD8A and colorectal carcinoma.